Project Grant R21DE035664
- The National Institute of Dental and Craniofacial Research awarded Duke University $444,125 on September 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate central nervous system and autonomic correlates of temporomandibular disorder pain. The research characterizes how altered brainstem circuit activity and brain glymphatic flow relate to autonomic dysfunction in patients with chronic painful temporomandibular disorder (TMD). The project measures...
- The National Institute of Dental and Craniofacial Research awarded the University of Rochester $111,828 on January 8, 2027, under the Oral Diseases and Disorders Research program (CFDA 93.121) to fund fellowship training in neural circuit research related to temporomandibular joint disorder. The project investigates central nervous system dysfunction underlying temporomandibular joint disorder pathophysiology, specifically testing the hypothesis that alterations in amygdala-brainstem circuitry...
- The National Institute of Dental and Craniofacial Research awarded the University of Washington $623,593 on September 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate the role of P75 neurotrophin receptor (P75NTR) in temporomandibular joint (TMJ) cartilage homeostasis and degenerative disease. The research defines cellular and molecular mechanisms regulating TMJ cartilage health and degeneration, with the goal of developing novel therapeutic strategies...
- The National Institute of Dental and Craniofacial Research awarded Massachusetts General Hospital $408,951 on February 15, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121, R21DE034917) to investigate photochemical tissue passivation as a treatment approach for temporomandibular joint osteoarthritis. The research applies photocrosslinking of tissue proteins—specifically collagen—through rose bengal solution and green light exposure to reduce inflammation and prevent...
- The National Institute of Dental and Craniofacial Research awarded $310,274 to the University of North Carolina at Chapel Hill on August 28, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121). The award funds a multidimensional phenotyping study characterizing the molecular, sensory, and psychosocial factors underlying comorbid temporomandibular disorder and migraine in adolescents. The project recruits 140 youth aged 10 to 17 years with TMD myalgia, stratified by the...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Children's Hospital of Philadelphia Research Institute a $507,006 Project Grant on August 1, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate the role of hyaluronan in YAP (Yes-associated protein) signaling on temporomandibular joint (TMJ) health and pathology. The research will be conducted over a two-year period through July 31, 2027, and focuses...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research awarded a Project Grant of $239,405 to Massachusetts General Hospital (The General Hospital Corporation) for the period July 1, 2025 through June 30, 2027, under the Oral Diseases and Disorders Research program (CFDA 93.121). The research focuses on elucidating the neural circuit mechanisms underlying peripheral nerve stimulation (PNS) as a treatment for trigeminal neuropathic pain (TNP), a condition...
- The National Institute of Dental and Craniofacial Research awarded New York University $656,068 on August 3, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to fund research into the neuronal mechanisms of lingual mechanosensation and nociception. The research investigates the molecular identities and functional roles of oral mechanosensory neurons and their contributions to oral health and pain disorders. The work focuses on tongue-innervating trigeminal neurons and...
- The National Institute of Dental and Craniofacial Research awarded The Ohio State University $690,195 on March 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate neuroimmunological mechanisms regulating reparative dentinogenesis in response to deep tooth injuries and inflammation. The project examines how calcitonin gene-related peptide (CGRP) derived from sensory neurons regulates immune and mineralizing cell responses during tooth healing, specifically...
- The National Institute of Dental and Craniofacial Research awarded Trustees of Boston University $249,000 on May 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate neutrophil-sensory neuron interactions in dental pulp inflammation and pain. The research addresses pulpitis, an inflammatory disease of the dental pulp currently managed through invasive procedures such as root canal therapy and tooth extraction. The project examines how neutrophils drive...
The National Institute of Dental and Craniofacial Research awarded The University of Texas Health Science Center at San Antonio $433,125 on August 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate neuronal-glial coupling mechanisms in temporomandibular joint pain. The project examines the role of connexin 43, a gap junction protein expressed in satellite glial cells, in modulating trigeminal ganglion neuron-glia communication and pain processing in vivo. The research uses in vivo voltage and calcium imaging combined with optogenetic glial manipulation to visualize and manipulate neuron-glia signaling networks in living animals. Specific Aim 1 characterizes in vivo trigeminal ganglion neuronal voltage dynamics in response to various sensory stimuli to investigate whether connexin 43 mediates neuron-glia signaling during temporomandibular joint pain. Specific Aim 2 establishes the causal role of satellite glial cell activity in driving maladaptive trigeminal ganglion neuronal activation using in vivo calcium and voltage imaging and selective optogenetic activation of satellite glial cells. The work addresses temporomandibular joint disorders, chronic orofacial pain conditions affecting 5–12 percent of adults and resulting in persistent jaw pain, jaw dysfunction, and reduced quality of life. Performance occurs in San Antonio, Texas through July 31, 2028. The award is classified as a Project Grant, an assistance type supporting research and development activities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $433.1k | 7/27/26 |